[
  {
    "ts": null,
    "headline": "A Look At Elevance Health (ELV) Valuation After Earnings Growth And Softer 2026 Outlook",
    "summary": "What the latest earnings and guidance tell you about Elevance Health Elevance Health (ELV) just reported fourth quarter and full year 2025 results alongside fresh 2026 guidance, giving you an updated read on revenue trends, profitability, and management’s expectations for the coming year. For 2025, Elevance Health reported full year revenue of US$199.1b compared with US$177.0b a year earlier, while net income was US$5.7b versus US$6.0b and diluted EPS from continuing operations was US$25.21...",
    "url": "https://finnhub.io/api/news?id=54e6f7a366a8fdf5de3717b2f9cbd43babcad0d7e028d2c5b09aee93bca5562c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770555830,
      "headline": "A Look At Elevance Health (ELV) Valuation After Earnings Growth And Softer 2026 Outlook",
      "id": 138392978,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ELV",
      "source": "Yahoo",
      "summary": "What the latest earnings and guidance tell you about Elevance Health Elevance Health (ELV) just reported fourth quarter and full year 2025 results alongside fresh 2026 guidance, giving you an updated read on revenue trends, profitability, and management’s expectations for the coming year. For 2025, Elevance Health reported full year revenue of US$199.1b compared with US$177.0b a year earlier, while net income was US$5.7b versus US$6.0b and diluted EPS from continuing operations was US$25.21...",
      "url": "https://finnhub.io/api/news?id=54e6f7a366a8fdf5de3717b2f9cbd43babcad0d7e028d2c5b09aee93bca5562c"
    }
  },
  {
    "ts": null,
    "headline": "How Investors May Respond To Elevance Health (ELV) Mixed Results, Softer 2026 Outlook And Higher Payouts",
    "summary": "Elevance Health has reported past fourth-quarter 2025 revenue of US$49,747 million and full-year revenue of US$199.13 billion, with full-year net income easing to US$5,662 million and diluted EPS from continuing operations at US$25.21. Alongside this mixed profit picture, the company signaled a low single digit decline in 2026 operating revenue, while still raising its quarterly dividend to US$1.72 per share and continuing share repurchases. Next, we’ll examine how softer 2026 earnings...",
    "url": "https://finnhub.io/api/news?id=23ab228672bf82fd2a3cb9699706401ffd3620dd88122e57fcf55cef7ee1167c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770527021,
      "headline": "How Investors May Respond To Elevance Health (ELV) Mixed Results, Softer 2026 Outlook And Higher Payouts",
      "id": 138390698,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ELV",
      "source": "Yahoo",
      "summary": "Elevance Health has reported past fourth-quarter 2025 revenue of US$49,747 million and full-year revenue of US$199.13 billion, with full-year net income easing to US$5,662 million and diluted EPS from continuing operations at US$25.21. Alongside this mixed profit picture, the company signaled a low single digit decline in 2026 operating revenue, while still raising its quarterly dividend to US$1.72 per share and continuing share repurchases. Next, we’ll examine how softer 2026 earnings...",
      "url": "https://finnhub.io/api/news?id=23ab228672bf82fd2a3cb9699706401ffd3620dd88122e57fcf55cef7ee1167c"
    }
  }
]